Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 20;11(3):38.
doi: 10.3390/tomography11030038.

Discussion of a Simple Method to Generate Descriptive Images Using Predictive ResNet Model Weights and Feature Maps for Recurrent Cervix Cancer

Affiliations

Discussion of a Simple Method to Generate Descriptive Images Using Predictive ResNet Model Weights and Feature Maps for Recurrent Cervix Cancer

Destie Provenzano et al. Tomography. .

Abstract

Background: Predictive models like Residual Neural Networks (ResNets) can use Magnetic Resonance Imaging (MRI) data to identify cervix tumors likely to recur after radiotherapy (RT) with high accuracy. However, there persists a lack of insight into model selections (explainability). In this study, we explored whether model features could be used to generate simulated images as a method of model explainability.

Methods: T2W MRI data were collected for twenty-seven women with cervix cancer who received RT from the TCGA-CESC database. Simulated images were generated as follows: [A] a ResNet model was trained to identify recurrent cervix cancer; [B] a model was evaluated on T2W MRI data for subjects to obtain corresponding feature maps; [C] most important feature maps were determined for each image; [D] feature maps were combined across all images to generate a simulated image; [E] the final image was reviewed by a radiation oncologist and an initial algorithm to identify the likelihood of recurrence.

Results: Predictive feature maps from the ResNet model (93% accuracy) were used to generate simulated images. Simulated images passed through the model were identified as recurrent and non-recurrent cervix tumors after radiotherapy. A radiation oncologist identified the simulated images as cervix tumors with characteristics of aggressive Cervical Cancer. These images also contained multiple MRI features not considered clinically relevant.

Conclusion: This simple method was able to generate simulated MRI data that mimicked recurrent and non-recurrent cervix cancer tumor images. These generated images could be useful for evaluating the explainability of predictive models and to assist radiologists with the identification of features likely to predict disease course.

Keywords: ResNet; XAI; cervix cancer; deep learning; generated images; machine learning; model explainability; most important feature maps; radiation therapy; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Overview of algorithm workflow to generate simulated data.
Figure 2
Figure 2
Sample Feature Maps from predictive Residual Neural Network (ResNet) Trained on T2-Weighted (T2W) Magnetic Resonance Imaging (MRI) data to identify recurrent vs. non-recurrent cervix cancer tumors for women with cervix cancer who had undergone radiotherapy treatment.
Figure 3
Figure 3
Generated Simulated MRI Images from predictive Residual Neural Network (ResNet) trained on T2-Weighted (T2W) Magnetic Resonance Imaging (MRI) data to identify recurrent vs. non-recurrent cervix cancer tumors for women with cervix cancer who had undergone radiotherapy treatment.

Similar articles

References

    1. Buskwofie A., David-West G., Clare C.A. A Review of Cervical Cancer: Incidence and Disparities. J. Natl. Med. Assoc. 2020;112:229–232. doi: 10.1016/j.jnma.2020.03.002. - DOI - PubMed
    1. Quinn M., Benedet J., Odicino F., Maisonneuve P., Beller U., Creasman W., Heintz A., Nan H., Pecorelli S. Carcinoma of the Cervix Uteri. Int. J. Gynecol. Obstet. 2006;95:S43–S103. - PubMed
    1. Chino J., Annunziata C.M., Beriwal S., Bradfield L., Erickson B.A., Fields E.C., Fitch K., Harkenrider M.M., Holschneider C.H., Kamrava M., et al. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract. Radiat. Oncol. 2020;10:220–234. doi: 10.1016/j.prro.2020.04.002. - DOI - PMC - PubMed
    1. Chen S., Chen Y., Yu L., Hu X. YTHDC1 inhibits cell proliferation and angiogenesis in cervical cancer by regulating m6 A modification of SOCS4 mRNA. Mol. Cell. Toxicol. 2024;20:533–540. doi: 10.1007/s13273-023-00360-3. - DOI
    1. Wen Y., Liang H., Zhang H. Clinical utility of HPV typing and quantification combined with PAX1/ZNF582 methylation detection in accurate cervical cancer screening. CytoJournal. 2023;20:26. - PMC - PubMed